Vasomotor symptoms (VMS), like hot flashes and night sweats, are common menopause symptoms. They’re likely the result of hormonal fluctuations that affect how your body controls its temperature.

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Objective: To update and expand The North American Menopause Society’s evidence-based position on nonhormonal management of menopause-associated vasomotor symptoms (VMS), previously a portion of ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

There are estrogen receptors in your breast tissue, which means a drop in estrogen can lead to breast changes, Dr. Streicher ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Neurokinin is a specific neurotransmitter (cell signaler) in the hypothalamus of the brain that is linked to vasomotor symptoms during menopause. Neurokinin-1 is thought to be linked to the body ...

Those with greater menopausal symptoms had higher scores ... “It is believed that the vasomotor symptoms are correlated with development of white matter hyperintensities in the brain, akin ...

For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive ...

Simon J, Pinkerton J, Maki P, et al. Efficacy of elinzanetant for the treatment of vasomotor symptoms associated with menopause: pooled data from two phase 3 studies. Presented at: AMCP 2025 ...